Search

Showing "11155" results for ""

Scoring tool predicts risk of KS progression

Boosted protease inhibitors have 60% lower risk of resistance compared with other classes

New type of Kaposi’s sarcoma seen in HIV-negative gay men

Nucleoside levels in seminal fluid higher than in blood, but not inside cells

Insulin resistance means coinfected patients have a poorer response to hepatitis C treatment

`Liver stiffness` and insulin resistance connection in HIV/hepatitis C coinfected patients

Significant, if limited, effects seen in safer-sex interventions for black American heterosexuals

First-line antiretroviral therapy: not as simple as we'd like it to be

Anti-HIV treatment may mean that progression of hepatitis C no worse in coinfected patients than in those with only hepatitis C

Ribavirin levels after four weeks of treatment predict which HIV/hepatitis C coinfected and re-treated patients will respond

HIV-positive gay men and sexual transmission of hepatitis C: it's no longer just northern Europe

HIV and hepatitis coinfection in Africa: studies provide conflicting prevalence data

Around 10% of HIV-positive patients without hepatitis B virus or hepatitis C virus found to have signs of liver damage

Prognosis of HIV/HCV-coinfected patients may be better than previously thought

Predicting which HIV/HCV-coinfected patients will respond to HCV treatment: some expected and some surprising answers

Fourteen-week nevirapine prophylaxis for infants reduces postnatal HIV infection

Improvement in anaemia in majority of US patients after starting AZT reported in large review

Atazanavir approved for first-line treatment in Europe

Receive the latest HIV research and conference news

Showing "11155" results for ""

Scoring tool predicts risk of KS progression

Boosted protease inhibitors have 60% lower risk of resistance compared with other classes

New type of Kaposi’s sarcoma seen in HIV-negative gay men

Nucleoside levels in seminal fluid higher than in blood, but not inside cells

Insulin resistance means coinfected patients have a poorer response to hepatitis C treatment

`Liver stiffness` and insulin resistance connection in HIV/hepatitis C coinfected patients

Significant, if limited, effects seen in safer-sex interventions for black American heterosexuals

First-line antiretroviral therapy: not as simple as we'd like it to be

Anti-HIV treatment may mean that progression of hepatitis C no worse in coinfected patients than in those with only hepatitis C

Ribavirin levels after four weeks of treatment predict which HIV/hepatitis C coinfected and re-treated patients will respond

HIV-positive gay men and sexual transmission of hepatitis C: it's no longer just northern Europe

HIV and hepatitis coinfection in Africa: studies provide conflicting prevalence data

Around 10% of HIV-positive patients without hepatitis B virus or hepatitis C virus found to have signs of liver damage

Prognosis of HIV/HCV-coinfected patients may be better than previously thought

Predicting which HIV/HCV-coinfected patients will respond to HCV treatment: some expected and some surprising answers

Fourteen-week nevirapine prophylaxis for infants reduces postnatal HIV infection

Improvement in anaemia in majority of US patients after starting AZT reported in large review

Atazanavir approved for first-line treatment in Europe

Receive the latest HIV research and conference news